Charles Joseph Epstein, M.D., 1933–2011, In Memoriam  by Wynshaw-Boris, Anthony et al.
OBITUARY
Charles Joseph Epstein, M.D., 1933–2011, In Memoriam
Anthony Wynshaw-Boris,1,* Neil Risch,1,* and Arno Motulsky2,*Charles Joseph Epstein, M.D., died on February 15, 2011,
at the age of 77, after a year-long battle with pancreatic
cancer. Charlie had a remarkable career as a scientist, clini-
cian, educator, and leader in the human and medical
genetics community. Charlie was the recipient of the two
major awards of The American Society of Human Genetics
(ASHG) in addition to serving as its President (1996) and
as the editor of The American Journal of Human Genetics
(AJHG), the Society’s journal, for seven years (1987–
1993). His impact and influence was immense, and he
will be greatly missed.
Charlie grew up in Philadelphia, where his Ukrainian
Jewish parents settled after separately immigrating to the
United States in 1921. He was the second of three sons
and grew up in an environment that was loving and
supportive but demanding. There was a strong devotion
to family, and the Epstein brothers remained close
throughout their lives. Excellence was expected, and
Charlie did not disappoint, nor did his two brothers,
Herbert (older) and Edwin (younger); all being accom-
plished scholars.
Charlie’s Hebrew name was Bezalel Joseph. Sometimes
an individual’s life reflects that of his namesake, but in
this case the correspondence is truly remarkable. In the
Bible, Bezalel was a talented builder and architect of the
Tabernacle, and Joseph was known for his strong and
courageous leadership. Charlie embodied both, bringing
talent, creativity, and heart to everything he built and led.
Charlie’s skill and ability manifested themselves early. In
addition to excelling in school, he built model airplanes,
ships, and crystal radios with precision. He played the
cello. He was an eagle scout. He ran track; his event, the
440 yard dash, requires a perfect balance of speed and
endurance. And his thirst for knowledge never ceased. He
would continue to have broad scholarly and extracurric-
ular activities throughout his life.
Charlie also had an independent streak. In addition to
choosing cello over the expected piano, Charlie decided
to attend Harvard College rather than the University of
Pennsylvania, even though both his brothers attended
Penn, the local Ivy League school. His move to Boston
was enabled by receipt of a coveted Harvard scholarship,
and he enthusiastically went to Boston. This decision
was quite fortuitous, however, because soon after arriving
at Harvard, Charlie met Lois Barth, a Radcliffe student1Institute for Human Genetics, University of California, San Francisco School o
sion of Genetics) and Genome Sciences, University of Washington School of
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a chemistry concentrator at Harvard and graduated summa
cum laude. He and Lois then attended Harvard Medical
School together, where Charlie graduated first in his class
and magna cum laude. Charlie then did a residency in
internal medicine and pathology, while Lois did one year
of pathology at Brigham and Women’s Hospital followed
by a year of internship in internal medicine at New
England Center Hospital.
As detailed in his Allen Award address,1 Charlie took
a somewhat unusual path into the field of genetics. He
decided to pursue laboratorywork at theNational Institutes
of Health (NIH) with Christian Anfinsen on protein struc-
ture and function. In particular, Anfinsen was pursuing
the idea that the 3D structure of a protein is determined
by its amino acid sequence, and he won the Nobel prize
for proving this theory. Charlie was given the task of dena-
turing and then refolding trypsin. Charlie felt that his time
in the Anfinsen lab fostered his independence in research
because Anfinsen left for a prolonged trip soon after Char-
lie’s arrival. Charlie was able to make his own decisions
about his research directions and approaches that allowed
him to grow as an independent scientist, but he also knew
that he did not want to become a protein chemist. This
was also the timewhenmolecular geneticswas blossoming,
and Charlie’s work in the Anfinsen lab underscored the
importance of genetics in understanding protein structure
and function in health and disease. To be oriented in the
nascent field of medical genetics and obtain clinical
genetics training, Charlie went to the University of Wash-
ington in Seattle with one of us (A.M.). Seattle had one of
the few programs providing such training. He studied
Werner syndrome, the beginning of a life-long interest in
aging. He returned to the NIH as a postdoctoral fellow after
his Seattle stay, and his interest in medical genetics was
fostered by attendance at half-day genetics conferences
led by Victor McKusick at Johns Hopkins.2
Charlie and Lois then moved to the Department of
Pediatrics at the University of California, San Francisco
(UCSF) School of Medicine in 1967, and they spent their
entire academic careers there (Lois was based in the Cancer
Research Institute). Charlie was hired as the first Chief of
the UCSF Division of Medical Genetics in the Department
of Pediatrics, one of the first divisions of medical genetics
in the nation. He led this division for 40 years. Hef Medicine, San Francisco, CA 94143, USA; 2Departments of Medicine (Divi-
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Figure 1. Portrait of Charles Joseph Epstein
Charles J. Epstein, portrait taken in 2009. Photo courtesy of the
Buck Institute.established a model genetics clinic and prenatal genetics
services as well as satellite clinics to provide care to the
Bay Area and much of Northern California. For years,
Charlie led the Program in Human Genetics at UCSF and
was a leading force in the formation of the Institute for
Human Genetics at UCSF, recruiting one of us (N.R.) as
the first director. This institute now has more than 60
faculty and celebrated its fifth anniversary this past year.
Outside of UCSF, Charlie had a major influence on another
Bay Area scientific institute, the Buck Institute for Research
on Aging, serving on its scientific advisory board and the
board of trustees for many years (Figure 1). Thus, Charlie’s
impact on the scientific and medical community of UCSF
and the greater Bay Area was immense.
Charlie was the consummate physician-scientist. His
major research interests were in the genetics of early
embryonic development, the pathogenesis of Down
syndrome, genetic approaches to the study of free radical
defense mechanisms, and aging.1 He authored over 300
peer-reviewed articles, more than 150 reviews and chap-
ters, and several books. He first decided to use the mouse
model when starting his own lab to study early preimplan-
tation mouse development and made important discov-
eries regarding the timing of initiation of X chromosome
inactivation. These studies convinced him of the power
of using a mammalian model such as the mouse for
studying problems important for understanding human
genetic diseases. Charlie was always thinking (and writing)
about mechanisms that cause birth defects, and his orig-
inal ideas were influential. Two examples stand out. First,
Charlie hypothesized that the abnormalities found in
Down syndrome were due to an increased dosage of critical
genes on chromosome 21. This was not the favored model
at the time. One of the first genes identified on human
chromosome 21 was the interferon-alpha receptor geneThe Ame(IFNAR1). This was a fortuitous coincidence because Lois
(who was also a scientific colleague and collaborator) was
an international expert on interferon. So Lois and Charlie
set out to study the binding of interferon to euploid and
trisomy 21 cells. They found that 50% more interferon
bound to trisomic cells than euploid cells, and the trisomy
21 cells were as much as 10 times more sensitive to the
effects of interferon. Similar studies were performed to
identify mouse chromosome 16 as a partial homologue
for human chromosome 21. To further support this model,
Charlie studied mice with partial trisomies for regions of
the mouse chromosomes homologous to human 21, thus
producing the first mouse model of Down syndrome.
The findings resulting from these and other studies led to
a landmark monograph on chromosome imbalance.3
Superoxide dismutase 1 (SOD1) was another gene residing
on chromosome 21; Charlie investigated the role of SOD1
and other homologs in free radical metabolism and aging,
an extension of his earlier work onWerner’s syndrome. He
was also one of the first to formulate the conception that
birth defects are caused by mutations in genes that act as
pathways—inborn errors of development—similar to
biochemical pathways.4 These examples—the study of
human diseases such as Down syndrome with mouse
models and the concept of inborn errors of develop-
ment—also illustrate the integration of the basic principles
of human genetic diseases with clinical genetics that was
a hallmark of Charlie’s contribution to the field and was
a major motivating force in his research. In fact, Charlie
was co-editor (with Bob Erickson and A.W.-B.) of a book
Inborn Errors of Development: The Molecular Basis of Clinical
Disorders of Morphogenesis.5 As Charlie noted in his
McKusick Leadership Award address at last year’s ASHG
meeting2, ‘‘The science is finally catching up to the clinic.’’
Charlie established training programs for genetics in
pediatrics, medicine, and obstetrics and gynecology; these
programs ultimately resulted in the establishment of
medical genetics and maternal-fetal medicine/medical
genetics fellowships at UCSF. He was instrumental in
providing the clinical and much of the didactic training
for the Genetic Counselor graduate program at University
of California, Berkeley between 1974–2004, when the
program ceased operation. Of particular historical interest,
one individual that welcomed Charlie to the Bay Area and
his role at UCSFwas Curt Stern (then a genetics professor at
University of California, Berkeley and after whom the
ASHG Stern Award is named). Curt took advantage of his
relationship with Charlie to seek professional advice for
his daughter, Holly Stern Ynostroza, who had a concern
about a possible genetic condition in her newborn
daughter. Of course, Charlie graciously agreed to see Holly
and her daughter and was pleased to inform her that her
child was normal (see the attached hand-drawn and signed
pedigree of the Stern-Ynostroza family, Figure 2).
Charlie trained more than fifty research fellows in
medical genetics and more than one hundred medical
genetics resident/fellows and genetic counselors (Figure 3),rican Journal of Human Genetics 88, 684–688, June 10, 2011 685
Figure 2. The Stern-Ynostroza Family Pedigree
The pedigree of the Stern-Ynostroza family, prepared and signed by Dr. Charles J. Epstein in 1973. Courtesy of Holly Stern Ynostroza.many of whom now head their own divisions and are
leaders in academia and in industry. He taught countless
numbers of medical and graduate students over those
years. He was a personal friend and mentor to many
trainees and faculty not only at UCSF but across the
country and internationally. He believed that his role was
to produce independent scientists, physicians, genetic
counselors, and colleagues. He mentioned several times
that his mentors fostered independence in him by allow-
ing him ‘‘to decide what needed to be done and how to
do it by myself’’2. However, he also acknowledged how
much he learned from his trainees. In his Leadership
Award address,2 Charlie noted, ‘‘Although I was officially
their mentor, I believe in many ways they were the
mentors and I was the student.’’ This bidirectional
mentor-trainee relationship was clearly successful, as
demonstrated by the number of successful leaders he has
trained in medical genetics research, clinical practice, and
genetic counseling.
Charlie was a national and international leader in
human andmedical genetics, and he influenced all aspects
of genetics. He served for seven years as a highly respected
editor of AJHG, the premier human genetics journal and
the Society’s journal. He was elected as President of the
three major American human andmedical genetics organi-
zations—the scientifically oriented ASHG, the clinically
oriented American College of Medical Genetics (ACMG),
and the American Board of Medical Genetics (ABMG)
that tests the knowledge of medical geneticists. The
ABMG was originally created in the early 1980s to certify
medical geneticists and genetic counselors and to accredit
training programs. However, the ABMG was not recog-
nized by the American Board of Medical Specialties
(ABMS) and attempts in the 1980s to join the ABMS were
unsuccessful. An opportunity presented itself in 1991,
and Charlie was one of the driving forces behind medical686 The American Journal of Human Genetics 88, 684–688, June 10,genetics becoming an accredited medical specialty
accepted by the ABMS. The most difficult aspect of this
process was that the ABMS refused to include genetic coun-
selors, who did not have MD degrees. As President of the
ABMG and editor of the AJHG, Charlie took the lead by
writing an editorial in The Journal and holding sessions at
the annual ASHG meeting; these actions were decisive in
obtaining the two-thirds approval vote of ABMGmembers
needed to join the ABMS. Because 40% of the ABMG
consisted of genetic counselors, this was quite a feat and
would not have been possible without Charlie’s leadership.
The independent American Board of Genetic Counseling
for genetic counselors and the National Society of Genetic
Counselors have both been remarkably successful, a fact
that was especially gratifying for Charlie.
Charlie has received all of the major awards of these
genetic organizations. He received the William Allen
Award from the ASHG in 2001 for his research on mouse
models of Down syndrome, and the McKusick Leadership
Award, which is awarded to an individual whose achieve-
ments have fostered and enriched the development of
various human genetics disciplines in 2010, presented to
Charlie this past November at the ASHG meeting. Charlie
posthumously received the ACMG Foundation Lifetime
Achievement Award at the 2011 ACMG meeting in
Vancouver in March. UCSF and the Buck Institute have
established a chair and lectureships. The Charles J. Epstein
Professorship in Human Genetics and Pediatrics for the
chief of the Division of Medical Genetics was established
in honor of his pioneering role in developing the division
ofmedical genetics. One of us was named to that Professor-
ship (A.W.-B.), much to Charlie’s delight (and enabling his
well-deserved retirement!). To recognize the many contri-
butions made by Charlie and Lois to UCSF, the Charles
and Lois Epstein Visiting Professorship was established.
Appropriately, the first recipient, in 2010, was Terry2011
Figure 4. Epstein Family Portrait
The Epstein family gathered at the Epstein house in Tiburon for
a combined 70th birthday party for Charlie and Lois. Photograph
courtesy of Lois Epstein.
Figure 3. Charles Joseph Epstein at Rounds with Fellows and
Genetics Counselors
Medical genetics teaching rounds with staff, fellows, and genetic
counselors. Photograph courtesy of Vicki Cox.Magnuson, a former trainee of Charlie’s who is now the
Chair of the Department of Genetics at the University of
North Carolina. Finally, the Buck Institute established
a lectureship in his honor, and the first lecturer this year
was Nobel laureate Stanley Prusiner from UCSF. The chair
and lectureships will insure that his profound influence
on UCSF and Bay Area institutions will be known for
generations to come.
Charlie was one of the victims of terror by the Unabom-
ber in 1993, and the attack nearly ended his life. He sus-
tained permanent damage to his hearing, lost the tips of
several fingers on his right hand, sustained nerve damage
to his right arm that required nerve transplant surgery,
and carried shrapnel from the attack with him for the
rest of his life. No doubt, he was targeted because of his
highly visible public persona in human genetics, and in
particular his role at the time as editor of AJHG. In spite
of all of these serious injuries, he worked courageously
and undauntedly to rehabilitate and continue his research,
clinical work, teaching, and service to the community. It
was after the attack that Charlie served as president of all
of the major genetics organizations listed above. He did
not shy away from using his experiences as a strong
personal motivation to raise the ethical and social issues
derived from the advances in human andmedical genetics,
as outlined in his ASHG Presidential Address.6 To see
Charlie return to research, teaching, clinical work, and
especially service to the genetics community was inspira-
tional.
Because of the strong connections he maintained
between his research and clinical work and because of his
strong ethical convictions, Charlie never lost sight of the
goals of his research. His awareness of how genetic condi-
tions are perceived by the public at large was no doubt
heightened after the Unabomber attack, but he was always
fully engaged in discussions regarding the ethics of human
genetics research and practice. He repeatedly emphasized
the importance of the individual human being in all theseThe Amediscussions and balanced the hopes and fears of society
and the goals and interests of science.1
Charlie has been characterized by many as a ‘‘mensch,’’
someone of strong character, integrity, and honor, and
one to be admired and emulated.How apt! Charlie’s ‘‘mens-
chlich’’ character wasmanifest in nearly everything he did,
both professional and personal. In addition to his remark-
able career as a scientist, clinician, educator, and leader in
the human and medical genetics community, Charlie led
an incredibly full life. Charlie and Lois sharednot only their
scientific collaboration but also a large extended family. As
known tomany, Charlie was devoted to Lois and their four
children, David, Paul, Jonathan, and Joanna, and his six
grandchildren (Figure 4) and was especially proud of each
of their accomplishments. Throughout his life he also re-
mained close to his two brothers Herbert and Edwin and
their children, as well as Lois’s extended family. Charlie
and Lois traveled all over the world, with their children
and grandchildren whenever possible, including road
trips and festive travel to Hawaii. Together they built
magnificent and intricate dollhouses and a lighthouse for
their six grandchildren; Charlie was an avid gardener and
took great pride in the exquisite garden he created at his
home in Tiburon (yet more evidence of Charlie, the archi-
tect). Charlie was very happy playing his cello in small
and large groups. He was particularly proud to be amember
of the Bohemian Club Orchestra, one of the oldest men’s
clubs in San Francisco. Charlie delighted in participating
in the finemusic-making of the orchestra (which consisted
of both amateur and professional musicians from the San
Francisco area). In spite of his injuries from the Unabomber
attack, he refused to give up the cello. He worked hard to
regain mobility in his fingers, took private lessons, and
returned to play with the orchestra for several years. In
fact, Charlie had to learn to pluck the cello strings with
his fifth finger on his right hand because the other fingers
on his right hand were so severely damaged from therican Journal of Human Genetics 88, 684–688, June 10, 2011 687
attack. It was very satisfying for him to be able to conduct
a Mozart bassoon concerto this past December near his
home in Marin County while his son Jonathan played the
bassoon solo part and his granddaughter Genevieve played
the cello in the orchestra.
Charlie’s legacy is enormous. His contributions in any
single domain of his remarkable career as a scientist, clini-
cian, educator, and leader in the human and medical
genetics community would amount to an extraordinary
legacy. That he contributed in all of these areas is a testa-
ment to the breadth of his intelligence, encyclopedic
knowledge of science, and strong sense of ethics. His
parting words at the end of hisMcKusick Leadership Award
speech,2 after acknowledging the support of the Society
and his family, were, ‘‘I have been truly blessed.’’ Indeed,
it is we, the human genetics community, that has been
blessed by the lifelong contributions of this towering
figure, a true mensch, talented architect, and courageous
leader.688 The American Journal of Human Genetics 88, 684–688, June 10,References
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